Atty. Mildred Conroy

At the firm’s New York office, Mildred Conroy is a partner in the Complex Litigation department. Since 2018, Mildred has been practicing law and fighting on behalf of clients who have been wronged by corporations. Mildred has considerable experience in Federal Court as an active and central member of several bellwether trial teams.

She is currently working on the opioid litigation, the Hair Relaxer MDL, the PFAS litigation and the class action for the train derailment in East Palestine, Ohio.

“My goal is to ensure that those who have been harmed by corporate negligence receive justice,” says Mildred. “It’s about holding corporations accountable for the damage they have caused.”

Prior to joining Simmons Hanly Conroy, Mildred was an associate at Lanier Law Firm. At both firms, her clients were those who suffered injuries or harm by defective products and corporate negligence.

While at Lanier, Mildred worked on the Depuy Orthopaedics Pinnacle Hip Implant litigation, the Johnson & Johnson talc trial in St. Louis, and the National Prescription Opiate litigation MDL 2804.

Mildred was a critical member of the trial teams that received the following settlements and verdicts:

• $350 million in settlements for the city of San Francisco from multiple drug manufacturers and distributors, including Walgreens, Endo, Allergan, Teva, Johnson & Johnson, AmerisourceBergen, Cardinal and McKesson
• More than $1 billion in two trials as part of the DePuy Pinnacle Hip Implant MDL 2244
• A unanimous $4.6 billion verdict against Johnson & Johnson on behalf of 22 women who suffered from and/or died from ovarian cancer caused by exposure to talcum powder
• Over $325 million in settlements for two Ohio counties as part of the first bellwether trial in the ongoing opioid multidistrict litigation (MDL 2804)
• $650 million from the abatement phase of the trial against CVS, Walgreens and Wal-Mart for two Ohio counties in the ongoing opioid multidistrict litigation (MDL 2804).

As part of the nationwide opioid litigation, Mildred also served on the trial team in San Francisco that secured a landmark victory for the people of San Francisco. Mildred’s particular focus was creating the liability storylines used each day in court as well as the overall day to day case management. This case was also a significant factor in driving Walgreen’s multibillion dollar, nationwide settlement.

In a milestone opinion, Judge Charles R. Breyer concluded that “the aggregate evidence that Plaintiff presented at trial was not only adequate to establish Walgreen’s culpability — it was devastating.”

• In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244
• Ingham v. Johnson & Johnson, No. 1522-CC10417-01 (Mo. Cir. Ct. Dec. 19, 2018)
• In re: National Prescription Opiate Litigation, case number 1:17-md-02804, in the U.S. District Court for the Northern District of Ohio
• County of Lake v. Purdue Pharma LP et al., case number 1:18-op-45032, County of Trumbull v. Purdue Pharma LP et al., case number 1:18-op-45079
• City and County of San Francisco, et al., v. Purdue Pharma L.P., et al., Case No. 3:18-cv-07591-CRB